31110000,RevMAb Biosciences,Rabbit Monoclonal,RevMAb Biosciences,+,兔单克隆,Array.Array.Array蚂蚁淘厂家直采.

Rabbit MonoclonalRevmab/Anti-Human IgG4 Fc Rabbit Monoclonal Antibody, Clone RM217/31-1100-00/1 Ea
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The recombinant antibodies are developed from a broad range of antigen-...
ProductDetailsProductNameAnti-HumanIgG4FcRabbitMonoclonalAntibody[RM217]ProductDescriptionRabbitmonoclonaltoHumanIgG4FcCatalogNo.31-1100-00CloneNameRM217ProductDataSheetAnti-HumanIgG4FcRabbitMonoclonalAntibodyDataSheetRM217SpecificityRM217reactstotheFcregionofhumanIgG4.NocrossreactivitywithhumanIgG1,IgG2,IgG3,IgM,IgA,IgD,IgE,mouseIgG,ratIgG,orgoatIgG.ImmunogenPeptidecorrespondingtotheFcregionofHumanIgG4ApplicationFlowCytometry
ELISA
SpeciesReactivityHumanConjugateNoneIntendedUseResearchUseOnly.PropertiesFormLiquidStorageInstructionsStoreat-20.0°CStABIlityStablefor1Yearat-20.0°CfromdateofreceiptStorageBuffer50%Glycerol/PBSwith1%BSAand0.09%sodiumazideVolume/ItemSize100ugConcentration1.0mg/mLPurityProteinAaffinitypurifiedfromananimalorigin–freeculturesupernatantCloneTypeMonoclonalIsotypeRabbitIgGUsageELISA:50ng/well–200ng/well(forCapture);
0.05ug/mL–0.2ug/mL(forDetection).

Keywords.ProductImages

RM217specificallyreactstohumanIgG4.Nocross
reactivity with human IgG1, IgG2, IgG3.

SandwichELISAusingRM217asthecapture
antibody, and Biotinylated anti-human light chains
( κ+ λ) antibody RM129 as the detection antibody,
followed by an AP conjugated streptavidin.

SandwichELISAusingRM217asthecapture
antibody, and Biotinylated anti-human light chains
( κ+ λ) antibody RM129 as the detection antibody,
followed by an AP conjugated streptavidin.

AtiterELISAusingRM217.Theplatewas
coated with different amounts of human IgG4.
A serial dilution of RM217 was used as the
primary antibody. An alkaline phosphatase
conjugated anti-rabbit IgG as the secondary
antibody.

RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.